Patent application number | Description | Published |
20100056699 | Process for Producing Organic Fiber-Containing Polyolefin Resin Composition - A production process of an organic fiber-containing polyolefin resin composition, comprising the step of mixing in a rotary impeller-carrying mixer (1) more than 10 parts by weight to less than 90 parts by weight of an organic fiber, with (2) more than 10 parts by weight to less than 90 parts by weight of a polyolefin resin containing (2-1) 50 to 100% by weight of polyolefin resin powders passing through a sieve having 2 mm openings, and (2-2) 0 to 50% by weight of polyolefin resin pellets not passing through a sieve having 2 mm openings and passing through a sieve having 4.75 mm openings. | 03-04-2010 |
20100320636 | FIBER-CONTAINING THERMOPLASTIC RESIN COMPOSITION AND PROCESS FOR PRODUCING THE SAME - A thermoplastic resin composition comprising (i) 55 to 95 parts by weight of a thermoplastic resin, and (ii) 5 to 45 parts by weight of a fiber containing 10 to 100% by weight of a diameter-varying fiber which has an enlarged diameter at its one or both ends; and a production process thereof comprising the steps of (1) cutting a continuous fiber under the condition that its cutting spot is heated to its melting temperature or higher, thereby preparing a diameter-varying fiber, and (2) melt-kneading a mixture containing the diameter-varying fiber and a thermoplastic resin. | 12-23-2010 |
20110144274 | PRODUCTION PROCESS OF OLEFIN POLYMERIZATION CATALYST AND OLEFIN POLYMER - A process for producing an olefin polymerization catalyst, comprising steps of (1) contacting a defined amount of a zinc compound represented by the defined formula, Zn(L | 06-16-2011 |
20110260096 | HEAT DISSIPATOR COMPRISING FOAM OF RESIN COMPOSITION - A heat dissipator comprising foam of a resin composition, which contains a thermoplastic resin, carbon fiber and a modified polyolefin modified by an unsaturated carboxylic acid or its derivative, wherein the resin composition has a melt flow rate of 5 g/10 minutes or more, and the foam has a foaming ratio of 1.05 to less than 1.70, and has thermal conductivity in a horizontal direction of 1 W/mK or more, and in a vertical direction of | 10-27-2011 |
20110263738 | EXPANSION MOLDED BODY AND METHOD FOR PRODUCING EXPANSION MOLDED BODY - A foamed article comprising a polyolefin resin composition (I) comprising a polyvinyl alcohol fiber (A), a polyolefin resin (B), and an unsaturated carboxylic acid-modified polyolefin resin and/or an unsaturated carboxylic acid derivative-modified polyolefin resin (C);
| 10-27-2011 |
20110293913 | RESIN COMPOSITION - A resin composition comprising a fiber component and a resin component, wherein | 12-01-2011 |
Patent application number | Description | Published |
20080317689 | Transdermal Preparation for External Use Containing Antiinflammatory/Analgesic Agent - A transdermal preparation for external use which contains a photosensitive NSAID and a UV blocker having a high ability to migrate into the skin. Thus, it becomes possible to ensure, in a transdermal preparation for external use containing a NSAID, the inhibition of the onset of light-induced non-immunological or immunological skin symptoms by the above-described component. | 12-25-2008 |
20100240758 | EXTERNAL PREPARATION FOR PERCUTANEOUS ADMINISTRATION CONTAINING NONSTEROIDAL ANTI-INFLAMMATORY ANALGESIC - An external preparation for percutaneous administration which contains a light-sensitive nonsteroidal anti-inflammatory analgesic and a UVA-shielding agent which inhibits the analgesic to cause light toxicity and a light allergy. This external preparation for percutaneous administration, which contains a nonsteroidal anti-inflammatory analgesic, can be prevented, with higher certainty, from causing the hypersensitivity to light attributable to light toxicity and a light allergy. | 09-23-2010 |
20100311700 | Transdermal preparation for external use containing nonsterioidal antiinflammatory/analgesic agent - A transdermal preparation for external use which contains a photosensitive NSAID and a UV blocker having a high ability to migrate into the skin. Thus, it becomes possible to ensure, in a transdermal preparation for external use containing a NSAID, the inhibition of the onset of light-induced non-immunological or immunological skin symptoms by the above-described component. | 12-09-2010 |
Patent application number | Description | Published |
20120238674 | RESIN COMPOSITION AND LIGHTING FIXTURE COMPONENTS MADE OF THE SAME - Disclosed is a resin composition including a thermoplastic resin (A), carbon fibers (B), graphite particles (C), an absorbent (D) selected from the group consisting of calcium hydroxide, zeolite, and hydrotalcite, and an antioxidant (E) or a combination of an antioxidant (E) and a compound (F) selected from a compound group consisting of compounds represented by C | 09-20-2012 |
20120238687 | RESIN COMPOSITION AND LIGHTING FIXTURE COMPONENT MADE OF THE SAME - Disclosed is a resin composition comprising from 40% by mass to 65% by mass of a thermoplastic resin (A), from 5% by mass to 10% by mass of carbon fibers (B), and from 30% by mass to 50% by mass of graphite particles (C) having an average particle diameter of larger than 12 μm and up to 50 μm where the total amount of the thermoplastic resin (A), the carbon fibers (B), and the graphite particles (C) shall be 100% by mass, wherein the melt flow rate measured at 230° C. and under a load of 2.16 kg in accordance with JIS-K-7210 is from 0.5 g/10 minutes to 30 g/10 minutes. A lighting fixture component made of the resin composition is also disclosed. | 09-20-2012 |
20120322935 | RESIN COMPOSITION AND INVERTER COMPONENT MADE OF THE SAME - The present aims to provide a resin composition having good molding processability and being capable of affording molded articles that exhibit high heat conductivity and high rigidity, and an inverter component made of this resin composition. The invention relates to a resin composition including 45% by mass to 60% by mass of a thermoplastic resin (A), 20% by mass to 40% by mass of carbon fibers (B), and 10% by mass to 35% by mass of graphite particles (C) having an average particle diameter of larger than 12 μm and up to 50 μm, wherein the total content of the carbon fibers (B) and graphite particles (C) is 40% by mass to 55% by mass, the melt flow rate of the resin composition measured at 230° C. under a load of 2.16 kg in accordance with JIS K7210 is 3 g/10 minutes to 30 g/10 minutes. | 12-20-2012 |
20140066574 | INJECTION MOLDED ARTICLE, AND METHOD FOR PRODUCING INJECTION MOLDED ARTICLE - Disclosed is an injection molded article made of a resin composition comprising 15 to 40% by mass of ultrahigh molecular weight polyethylene fibers, and 60 to 85% by mass of a thermoplastic resin having a melt flow rate of 70 to 500 g/10 min. measured at a temperature of 230° C. and a load of 21.2 N, and a fusion peak temperature lower than 160° C. measured with a differential scanning calorimeter, where the combined mass of the ultrahigh molecular weight polyethylene fibers and the thermoplastic resin is taken as 100% by mass, wherein the injection molded article satisfies the following requirements: the intrinsic volume resistivity is 1.0×10 | 03-06-2014 |
Patent application number | Description | Published |
20130053357 | SKIN IRRITATION SUPPRESSANT AND TRANSDERMAL PREPARATION - Provided is a skin irritation suppressant for transdermal preparations, having a sufficient reduction effect of skin irritation due to a drug. Also provided is a transdermal preparation comprising the skin irritation suppressant. One embodiment of the invention is a skin irritation suppressant for suppressing the skin irritation due to a drug and a pharmaceutical ingredient to be used in a transdermal preparation other than the drug, the skin irritation suppressant comprising a sterol compound selected from the group consisting of cholesterol, cholesterol derivatives and cholesterol analogs, and the drug is one or more basic drugs selected from the group consisting of tolterodine, asenapine, bisoprolol, risperidone, nicotine and citalopram, and their pharmaceutically acceptable salts. | 02-28-2013 |
20130053358 | TRANSDERMALLY ABSORBABLE DONEPEZIL-CONTAINING PREPARATION - Provided is a transdermal preparation having low skin irritation as well as a sufficient skin permeability rate of donepezil, which comprises one or more drugs selected from donepezil and pharmaceutically acceptable salts thereof. Also provided are a manufacturing method thereof, and a method for reducing skin irritation of a transdermally absorbable donepezil-containing preparation. An embodiment is a transdermal preparation comprising one or more drugs selected from donepezil and pharmaceutically acceptable salts thereof, and a skin irritation-reducing agent. | 02-28-2013 |
20140271796 | OXYBUTYNIN-CONTAINING TRANSDERMAL ABSORPTION PREPARATION - A transdermal absorption preparation containing at least one drug selected from oxybutynin and pharmaceutically acceptable salts thereof and 0.05% by mass or more of a sterol selected from cholesterols, cholesterol derivatives and cholesterol analogs, relative to a total amount of the transdermal absorption preparation. | 09-18-2014 |